These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36638187)

  • 41. Normalization of Hepatic Homeostasis in the
    Munkacsi AB; Hammond N; Schneider RT; Senanayake DS; Higaki K; Lagutin K; Bloor SJ; Ory DS; Maue RA; Chen FW; Hernandez-Ono A; Dahlson N; Repa JJ; Ginsberg HN; Ioannou YA; Sturley SL
    J Biol Chem; 2017 Mar; 292(11):4395-4410. PubMed ID: 28031458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.
    Cougnoux A; Movassaghi M; Picache JA; Iben JR; Navid F; Salman A; Martin K; Farhat NY; Cluzeau C; Tseng WC; Burkert K; Sojka C; Wassif CA; Cawley NX; Bonnet R; Porter FD
    Dig Dis Sci; 2018 Apr; 63(4):870-880. PubMed ID: 29357083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
    Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
    Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.
    Lopez AM; Terpack SJ; Posey KS; Liu B; Ramirez CM; Turley SD
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):780-7. PubMed ID: 25115571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heat shock protein amplification improves cerebellar myelination in the Npc1
    Gray J; Fernández-Suárez ME; Falah M; Smith D; Smith C; Kaya E; Palmer AM; Fog CK; Kirkegaard T; Platt FM
    EBioMedicine; 2022 Dec; 86():104374. PubMed ID: 36455410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.
    Rauniyar N; Subramanian K; Lavallée-Adam M; Martínez-Bartolomé S; Balch WE; Yates JR
    Mol Cell Proteomics; 2015 Jul; 14(7):1734-49. PubMed ID: 25873482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1.
    Meyer A; Wree A; Günther R; Holzmann C; Schmitt O; Rolfs A; Witt M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.
    Probert F; Ruiz-Rodado V; Vruchte DT; Nicoli ER; Claridge TDW; Wassif CA; Farhat N; Porter FD; Platt FM; Grootveld M
    Sci Rep; 2017 Jul; 7(1):6320. PubMed ID: 28740230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.
    Davidson CD; Ali NF; Micsenyi MC; Stephney G; Renault S; Dobrenis K; Ory DS; Vanier MT; Walkley SU
    PLoS One; 2009 Sep; 4(9):e6951. PubMed ID: 19750228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1.
    Wheeler S; Bhardwaj M; Kenyon V; Ferraz MJ; Aerts JMFG; Sillence DJ
    FEBS Lett; 2024 Feb; 598(4):477-484. PubMed ID: 38302739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
    Nicoli ER; Al Eisa N; Cluzeau CV; Wassif CA; Gray J; Burkert KR; Smith DA; Morris L; Cologna SM; Peer CJ; Sissung TM; Uscatu CD; Figg WD; Pavan WJ; Vite CH; Porter FD; Platt FM
    PLoS One; 2016; 11(3):e0152007. PubMed ID: 27019000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
    Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
    Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
    Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice.
    Hovakimyan M; Maass F; Petersen J; Holzmann C; Witt M; Lukas J; Frech MJ; Hübner R; Rolfs A; Wree A
    Neuroscience; 2013 Nov; 252():201-11. PubMed ID: 23948640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic expression of swallowing function in Niemann-Pick disease type C1.
    Solomon BI; Muñoz AM; Sinaii N; Farhat NM; Smith AC; Bianconi S; Dang Do A; Backman MC; Machielse L; Porter FD
    Orphanet J Rare Dis; 2022 Sep; 17(1):342. PubMed ID: 36064725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.
    Dominko K; Rastija A; Sobocanec S; Vidatic L; Meglaj S; Lovincic Babic A; Hutter-Paier B; Colombo AV; Lichtenthaler SF; Tahirovic S; Hecimovic S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice.
    Schlegel V; Thieme M; Holzmann C; Witt M; Grittner U; Rolfs A; Wree A
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1.
    Sidhu R; Kell P; Dietzen DJ; Farhat NY; Do AND; Porter FD; Berry-Kravis E; Reunert J; Marquardt T; Giugliani R; Lourenço CM; Wang RY; Movsesyan N; Plummer E; Schaffer JE; Ory DS; Jiang X
    Mol Genet Metab; 2020 Dec; 131(4):405-417. PubMed ID: 33257258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mass spectrometry imaging and LC/MS reveal decreased cerebellar phosphoinositides in Niemann-Pick type C1-null mice.
    Pathmasiri KC; Pergande MR; Tobias F; Rebiai R; Rosenhouse-Dantsker A; Bongarzone ER; Cologna SM
    J Lipid Res; 2020 Jul; 61(7):1004-1013. PubMed ID: 32371566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.
    Campbell K; Cawley NX; Luke R; Scott KEJ; Johnson N; Farhat NY; Alexander D; Wassif CA; Li W; Cologna SM; Berry-Kravis E; Do AD; Dale RK; Porter FD
    Biomark Res; 2023 Jan; 11(1):14. PubMed ID: 36721240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.